Previous reports suggest that cacalol has an anti-breast cancer effect by inhibiting fatty acid synthase (FAS) at transcriptional and post-transcriptional levels and modulating the Akt-SREBP (sterol regulatory element-binding protein) pathways. The gene discussed is FAS; the disease is breast carcinoma.